(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash, cash equivalents and federal funds sold | -78.52%29.41M | 18.42%174.62M | 18.42%174.62M | 326.98%91.84M | 419.97%90.05M | 471.88%136.91M | 385.41%147.45M | 385.41%147.45M | -72.53%21.51M | -58.15%17.32M |
-Cash and cash equivalents | -78.52%29.41M | 18.42%174.62M | 18.42%174.62M | 326.98%91.84M | 419.97%90.05M | 471.88%136.91M | 385.41%147.45M | 385.41%147.45M | -72.53%21.51M | -58.15%17.32M |
-Available for sale securities | -89.54%7.52M | ---- | ---- | --36.86M | -5.28%48.52M | --71.92M | -4.71%56.31M | -4.71%56.31M | ---- | 270.93%51.22M |
Derivative assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --17.78M |
Receivables | -7.98%4.56M | -75.58%1.37M | -75.58%1.37M | -68.43%1.88M | -70.98%2.34M | -29.18%4.95M | 4.87%5.6M | 4.87%5.6M | -24.68%5.95M | 213.01%8.06M |
Other assets | 27.71%1.06M | 13.86%1.03M | 13.86%1.03M | -36.91%646K | -32.00%733K | -27.76%830K | -27.43%902K | -27.43%902K | 425.13%1.02M | 331.20%1.08M |
Total assets | 2.33%3.39B | 13.55%3.82B | 13.55%3.82B | 8.21%3.64B | 6.60%3.53B | -6.60%3.32B | -6.10%3.37B | -6.10%3.37B | -10.52%3.36B | -7.69%3.31B |
Liabilities | ||||||||||
Derivative product liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --23.49M | ---- |
Payables | -70.51%12.82M | 113.96%130.38M | 113.96%130.38M | 102.44%96.06M | 63.39%82.2M | -53.62%43.48M | -41.68%60.94M | -41.68%60.94M | -63.76%47.45M | -57.37%50.31M |
-Accounts payable | -52.11%3.3M | -2.37%9.52M | -2.37%9.52M | -1.73%3.24M | -0.22%9.54M | 101.49%6.89M | 2.92%9.75M | 2.92%9.75M | 208.43%3.29M | 0.70%9.56M |
-Total tax payable | -79.34%106K | --0 | --0 | -55.81%152K | -3.33%174K | 205.36%513K | --331K | --331K | --344K | --180K |
-Other payable | -73.90%9.42M | 137.67%120.86M | 137.67%120.86M | 111.52%92.67M | 78.67%72.49M | -59.98%36.08M | -46.47%50.85M | -46.47%50.85M | -66.27%43.81M | -62.61%40.57M |
Long term debt and capital lease obligation | 0.10%497.96M | 0.10%497.83M | 0.10%497.83M | 0.10%497.7M | 0.11%497.57M | 0.10%497.44M | 0.10%497.31M | 0.10%497.31M | 0.11%497.18M | 0.10%497.05M |
Total liabilities | 2.20%611.02M | 21.02%736.76M | 21.02%736.76M | 5.50%680.4M | 6.20%654.52M | -10.88%597.9M | -10.72%608.8M | -10.72%608.8M | -12.22%644.95M | -13.16%616.29M |
Shareholders'equity | ||||||||||
Share capital | -1.95%1.41B | -2.09%1.41B | -2.09%1.41B | -2.20%1.42B | -1.76%1.43B | -1.10%1.44B | -2.12%1.44B | -2.12%1.44B | -1.90%1.45B | -6.87%1.45B |
-common stock | -1.95%1.41B | -2.09%1.41B | -2.09%1.41B | -2.20%1.42B | -1.76%1.43B | -1.10%1.44B | -2.12%1.44B | -2.12%1.44B | -1.90%1.45B | -6.87%1.45B |
Retained earnings | 7.23%1.88B | 20.14%2.18B | 20.14%2.18B | 18.79%2.04B | 18.99%1.91B | 4.69%1.75B | 11.52%1.81B | 11.52%1.81B | -1.33%1.72B | -2.27%1.61B |
Other equity interest | -172.10%-985K | 3.96%-364K | 3.96%-364K | -15.55%-327K | -16.61%-344K | -17.92%-362K | -18.81%-379K | -18.81%-379K | ---283K | ---295K |
Total stockholders'equity | 2.20%2.66B | 11.99%2.96B | 11.99%2.96B | 8.95%2.83B | 6.78%2.75B | -5.66%2.6B | -4.78%2.64B | -4.78%2.64B | -10.16%2.6B | -10.52%2.57B |
Noncontrolling interests | 5.61%126.07M | 9.87%126.06M | 9.87%126.06M | 6.70%124.52M | 4.88%125.99M | -4.53%119.37M | -10.11%114.74M | -10.11%114.74M | -8.72%116.69M | --120.12M |
Total equity | 2.35%2.78B | 11.90%3.08B | 11.90%3.08B | 8.85%2.96B | 6.69%2.87B | -5.61%2.72B | -5.02%2.76B | -5.02%2.76B | -10.10%2.72B | -6.34%2.69B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.